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Abstract 
Purpose: Although endometriosis is a benign disorder, recent studies suggest that endometriosis could be viewed as a 
neoplastic process. The objective of this study is to explore the epidemiology of synchronous neoplasms (SPN) in women with 
severe endometriosis. 
Patients & Methods: The prevalence of SPN in cases with endometriotic ovarian cysts that underwent surgery at “Lito” 
Maternity Hospital of Athens and at Anticancer Institute of Bucharest was investigated. The review period was from the year 2000 to 
2008. The medical records and pathology were reviewed to confirm the diagnosis and stage of tumors.  
Results: Five women with synchronous cancer of the genital tract were identified. All of our patients had a grade-I 
endometrioid carcinoma of the uterus (Ia in 3, Ib in 2). Myometrium was invaded in less than 1/3, in 4 cases, and less than ½ in one 
case. Similarly, 4 out of 5 ovarian cancers were endometrioid, while one was serum cystadenosarcoma. All of the ovarian 
malignancies were grade I (Ib in 3 and Ia in 2). The median diameter of the ovarian neoplasias was of 4.3cm, as opposed to 4.5cm 
that was the median diameter of all endometrioid cysts. When the larger ovarian malignant cyst in each patient was accounted, the 
median diameter was calculated as having 5.8cm. 
Conclusions: Women with synchronous primary cancers of the endometrium and ovary have distinct clinical characteristics 
including younger age, premenopausal status, and nulliparity. This suggests that a hormonal ‘‘field effect’’ may account for the 
development of these simultaneous endometrioid cancers, supporting the theory of estrogen receptors. 
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Introduction
Synchronous primary neoplasms (SPN) of the 
female reproductive tract represent a rare situation with a 
special clinical interest. It is an idiomorphous phenomenon 
with unknown pathogenesis and etiology. It occurs in 10% 
of all women with ovarian cancer and 5% of all women 
with endometrial cancer [1]. A first effort to delineate a set 
of pathologic criteria to distinguish the metastatic disease  
 
from synchronous primary tumors was made by Ulbright 
and Roth [2], in 1985. Nowadays, a similar but more 
extensive list of clinicopathologic features created by 
Scully et al. [3] is used to differentiate between 
endometrial cancer with metastasis to the ovary, ovarian 
cancer with metastasis to the endometrium, and 
independent primary cancers (Table 1). 
   
From Scully RE, et al. Tumors 
of the Ovary, Maldeveloped 
Gonads, Fallopian Tube and 
Broad Ligament, Atlas of 
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1998 
 
 
Table 1 Endometrioid tumors of the ovary and endometrium, Independent primary tumors 
Independent primary tumors 
1.  Histological dissimilarity of the tumors 
2.  No or only superficial myometrial invasion of endometrial tumor 
3.  No vascular space invasion of endometrial tumor 
4.  Absence of other evidence of spread of endometrial tumor 
5.  Atypical endometrial hyperplasia additionally present 
6.  Ovarian unilateral tumor (80-90%) of cases 
7.  Ovarian tumor located in parenchyma 
8.  No vascular space invasion, surface implants, or predominant hilar location in ovary 
9.  Absence of other evidence of spread of ovarian tumor 
10.  Ovarian endometriosis present 
11.  Different ploidy of DNA indices, if aneuploid, of the tumors 
12.  Dissimilar molecular genetic or karyotypic abnormalities in the tumors 
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In our institution, gynecologic pathologists use these 
criteria to determine whether the tumors of the 
endometrium and ovary represent a metastatic disease or 
independent primary tumors. The most common 
hypothesis about pathogenesis is that embryologically, 
similar tissues may develop synchronous neoplasms, 
when subjected to hormonal influences or to carcinogens. 
Primary malignancies of the ovary and endometrium have 
been investigated in many trials. In addition, 
endometriosis may be the precursor of clear cell or 
endometrioid ovarian cancer. The pathological and 
epidemiological evidence demonstrates a strong 
association with ovarian cancer as well. Estrogen 
receptors may be responsible for the development of 
multiple primary malignancies in predisposed tissue. 
Actually, the presence of endometriosis is associated with 
an increased risk of synchronous primary neoplasms 
mainly in ovary and endometrium. In our study, we 
present the frequency and types of synchronous cancers 
of female genital tract that appear in women surgically 
treated for endometriosis. 
Patients and methods 
In the present study, we investigated the prevalence 
of SPN in cases with endometriotic ovarian cysts that 
underwent surgery at “Lito” Maternity hospital of Athens 
and at Anticancer Institute of Bucharest. In our analysis, a 
total number of 811 women have been included, after 
clinical and ultrasound diagnosis of ovarian 
endometriomas (transvaginal ultrasound). All the patients 
underwent surgery and some of them underwent 
hysterectomy. The review period was from the year 2000 
to 2008. The medical records and pathology were 
reviewed to confirm the diagnosis and stage of tumors. 
Stage was assigned according to the FIGO criteria. 
Pathology specimens of SPN were reviewed to confirm 
original pathologic type and grade. The tumor grades for 
ovarian and endometrial cancer were assigned as it  
 
 
follows: grade I (well differentiated), grade II (moderately 
differentiated), grade III (poorly differentiated). 
Results 
During the reported period of time, 811 patients 
underwent surgery for the excision of ovarian 
endometriosis (severe endometriosis). The mean age of 
the women was 40.9 years old (19-68 years old). In 380 
(46.8%) cases the mass was located at the left adnexal, in 
294 (36.2%) in the right and in 137 (17%) women in both 
ovaries. Diameter of masses ranged from 2-15 cm, the 
median diameter being of 4.95 cm.  
Based on the pathologic reports, nine women with 
synchronous cancers of the genital tract were identified. 
After reviewing, though, the pathological sections 4 out of 
9 patients were identified as metastatic cases. So, five 
(0.62%) patients were identified as having synchronous 
primary neoplasms. The mean age of the five women was 
of 54.2 years old. Three patients were nulliparous. All of 
our patients had a grade-I endometrioid carcinoma of the 
uterus, while stage was Ia in 3 and Ib in 2. The 
myometrium was invaded less than 1/3 in 4 cases and 
less than 2/3 in all cases. In the case where carcinoma 
invaded more than 1/3 of the myometrium, simple atypical 
hyperplasia of the endometrium was also identified. 
Similarly, 4 out of 5 ovarian cancers were endometrioid, 
while one was serous cystadenosarcoma. All of the 
ovarian malignancies were grade I (three of them were 
staged with Ib and II as Ia). In two cases, ovarian 
malignancy was positive for HER-2/neu. The median 
diameter of the ovarian neoplasias was of 4.3cm, 
compared to 4.5cm that was the median diameter of all 
endometrioid cysts. When the larger ovarian malignant 
cyst in each patient was accounted, the median diameter 
was calculated as having 5.8cm. In two cases, ovarian 
malignancy was detected only to the right ovary, while to 
the rest it was bilateral. What is interesting is that in 2 out 
of 3 cases of bilateral ovarian malignancies the larger cyst 
was in the right ovary (Table 2). 
 
 
 
Table 2 Histopathological analysis of the 5 patients with synchronous primary carcinomas of the endometrium and ovary 
Case 
no  Histologic type and grade  Staging (FIGO)  Myometrial invasion  Involved ovaries  Endometriosis 
  Endo-metrium  Ovary  Endo-metrium  Ovary       
1  EN - I  EN  Ia  Ib  <1/3  R  + 
2  EN – I  CS  Ib  Ib  <1/3  B  + 
3  EN – I*  EN  Ia  Ia  <1/2  R  + 
4  EN – I  EN  Ia  Ia  <1/3  B  + 
5  EN – I  EN  Ib  Ia  <1/3  B  + 
 
 
 
 
 
 
EN: Endometrioid, CS: Serum cystedenosarcoma, R: Right, B: Bilateral 
*Simple atypical hyperplasia was also identified 
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Discussion 
The synchronous occurrence of endometrial and 
ovarian cancer is well known but still poses a diagnostic 
dilemma. A still existing diagnostic dilemma is the 
synchronous occurrence of malignancies of the female 
genital tract. In cases of different histologic types, the 
dilemma of which cancer is primary and which is 
metastatic remains. On the other hand, if the histologic 
types are different it is easy to identify the coexistence of 
the two primary cancers. Although immunohistochemical 
and DNA flow cytometric studies have been used to 
distinguish between neoplasms of similar histology, the 
differential diagnosis still lies primarily on conventional 
clinicopathologic criteria. It is important to separate 
women with two primary cancers from those with 
metastases, since prognosis is significantly better for the 
first group.  
The most frequently documented synchronous 
malignancies are those of the ovary and endometrium. It 
is well known the fact that the simultaneous malignancies 
are predominantly of low stage and this finding was 
confirmed by our study as well. Earlier studies suggested 
that women diagnosed with synchronous primary cancers 
have a better overall prognosis than if their disease was 
classified as single organ disease with metastasis [4-6]. A 
study undergone by the Gynecologic Oncology Group 
(GOG) on 74 patients with synchronous cancers of the 
genital tract, reported a 5-year survival of 86% and a 10- 
year survival of 80% (1). Few studies, however, focused 
on risk factors in these patients. 
Several hypotheses have been proposed regarding 
the simultaneous involvement of the endometrium and 
ovary. The most popular hypothesis concerning the 
pathogenesis of this extremely rare condition is that 
estrogen receptors may be responsible for the 
development of multiple primary malignancies in 
predisposed tissues. Another hypothesis is that an 
“extended” or secondary mullerian system exists, so that 
the similarity of the female’s upper genital tracts 
undergoing common metaplastic diseases could be 
explained. Endometriosis seems to be a precursor of a  
 
clear cell or endometrioid ovarian cancer. The 
histopathology and epidemiological evidence 
demonstrates a strong association between endometriosis 
and ovarian cancer.  
This is one of the few studies that, instead of 
focusing on women with synchronous neoplasms of the 
genital tract and identifying the percentage of 
endometriosis on them, goes the other way round; in a 
population with moderate and severe endometriosis we 
identified the prevalence of synchronous cancers. In our 
cohort, median age at diagnosis was of 54 years old in 
women with synchronous primary cancers of the 
endometrium and ovary. In contrast, women who develop 
endometrial or ovarian cancer alone are predominantly 
postmenopausal and in the sixth or seventh decade of life. 
Previous studies have also reported a younger median 
age in patients with synchronous primary endometrial and 
ovarian cancers. Eifel et al. [4] (n=29), in particular, found 
a younger than expected median age of 41 years old in 
women with endometrioid/endometrioid cancers, while 
GOG (n=74) reported a median age of 49 years old [1]. 
Herrinton et al. [7] reported that 39% of patients were 
under the age of 50 at the time of diagnosis in a case-
control study (n=56). Finally, in studies examining young 
women with endometrial cancer (age less than 45 years), 
10–29% of these young women were found with 
synchronous ovarian cancers [8,9].  
Our study indicates that women with synchronous 
primary cancers of the endometrium and ovary have 
distinct clinical characteristics including younger age, 
premenopausal status, and nulliparity. This suggests that 
a hormonal ‘‘field effect’’ may account for the development 
of these simultaneous endometrioid cancers, supporting 
the theory of estrogen receptors. Eifel et al. [4] also 
suggested that the response of the uterine corpus, 
fallopian tubes, and ovarian epithelium as a morphologic 
unit could explain the development of synchronous 
endometrioid tumors in different components of the 
mullerian system. Future studies are needed to further 
evaluate the role of estrogen in these synchronous 
endometrioid cancers of the endometrium and ovary. 
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